SCHEMBL2489203

SCHEMBL2489203

O=C(Cl)Oc1cccc(OC(=O)Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.60
MEN1 O00255 1/20 0.60
LMNA P02545 3/20 0.47
CYP3A4 P08684 1/20 0.47
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ACHE P22303 3/20 0.42
BCHE P06276 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16520280 0.91 KMT2A (0.52) KMT2AMEN1LMNACYP3A4NPC1
SCHEMBL2853759 0.89 CES2 (0.55) KMT2AMEN1LMNACYP3A4NPC1
SCHEMBL13719843 0.89 LMNA (0.63) KMT2AMEN1LMNACYP3A4NPC1
SCHEMBL8165449 0.87 CYP3A4 (0.66) KMT2AMEN1LMNACYP3A4CA1
SCHEMBL3884023 0.87 BCHE (0.50) KMT2AMEN1LMNANPSR1BCHE
SCHEMBL10795242 0.86 KMT2A (0.47) KMT2AMEN1LMNACYP3A4NPC1
SCHEMBL27829223 0.86 KMT2A (0.47) KMT2AMEN1LMNACYP3A4NPC1
SCHEMBL5580391 0.85 ESR1 (0.51) KMT2AMEN1LMNACYP3A4NPC1
SCHEMBL13461312 0.85 CYP3A4 (0.50) KMT2AMEN1LMNACYP3A4CA1
SCHEMBL5776640 0.85 KMT2A (0.56) KMT2AMEN1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102282154-B Dimeric avermectin and milbemycin derivatives MERIAL LTD 2015-07-01 CN disclosed
EP-2376513-B1 DIMERIC AVERMECTIN AND MILBEMYCIN DERIVATIVES MERIAL LTD (US) 2015-02-25 EP disclosed
EP-2376513-B1 DIMERIC AVERMECTIN AND MILBEMYCIN DERIVATIVES MERIAL LTD (US) 2015-02-25 EP disclosed
EP-1154734-B1 INJECTABLE COLLAGEN-BASED SYSTEM FOR DELIVERY OF CELLS PROCHON BIOTECH LTD (IL) 2014-10-01 EP disclosed
US-8426460-B2 Dimeric avermectin and milbemycin derivatives MERIAL LIMITED (US) 2013-04-23 US disclosed
US-8426460-B2 Dimeric avermectin and milbemycin derivatives MERIAL LIMITED (US) 2013-04-23 US disclosed
US-8426460-B2 Dimeric avermectin and milbemycin derivatives MERIAL LIMITED (US) 2013-04-23 US disclosed
CN-102282154-A Dimeric avermectin and milbemycin derivatives 2011-12-14 CN disclosed
EP-2376513-A1 DIMERIC AVERMECTIN AND MILBEMYCIN DERIVATIVES Merial Limited (US) 2011-10-19 EP disclosed
WO-2010065852-A1 DIMERIC AVERMECTIN AND MILBEMYCIN DERIVATIVES MERIAL LIMITED (US) 2010-06-10 WO disclosed
EP-0319990-B1 Process for preparing composite membranes DU PONT (US) 1993-10-20 EP disclosed
EP-0213925-B1 COPOLYMERIZABLE UV STABILIZERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-03-11 EP disclosed
EP-0319990-A2 Process for preparing composite membranes E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-06-14 EP disclosed
US-4831109-A Copolymerizable UV stabilizers MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-05-16 US disclosed
US-4783346-A INTERFACES, POLYAMIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-11-08 US disclosed
US-4691059-A Copolymerizable UV stabilizers MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1987-09-01 US disclosed
EP-0213925-A2 Copolymerizable UV stabilizers MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1987-03-11 EP disclosed
US-4366102-A Process for the preparation of chloroformic acid aryl esters BAYER AKTIENGESELLSCHAFT (DE) 1982-12-28 US disclosed
US-4258164-A Reticulate polymers based on oligourethanacrylates and method for their manufacture BERLIN ALFRED A 1981-03-24 US disclosed
US-4250322-A Oligourethanacrylates and methods for their manufacture ALTSHULER JUDIF M (SU) 1981-02-10 US disclosed